Sleep-wake regulation affects every person's life, yet the molecular mechanisms underlying these processes remain poorly understood. In particular, the microstructure of sleep has not been sufficiently studied to explain how sleep produces a feeling of restoration the following morning. Stress also plays a significant role in sleep regulation. This study aims to investigate the role of norepinephrine in these processes.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Total Sleep Time (TST)
Timeframe: Baseline Night, Experimental Night 1, Experimental Night 2, Experimental Night 3
Change in Wake After Sleep Onset (WASO)
Timeframe: Baseline Night, Experimental Night 1, Experimental Night 2, Experimental Night 3
Change in Sleep Efficiency
Timeframe: Baseline Night, Experimental Night 1, Experimental Night 2, Experimental Night 3
Change in Sleep Onset Latency (SOL)
Timeframe: Baseline Night, Experimental Night 1, Experimental Night 2, Experimental Night 3
Percentage of Time in N1, N2, N3 and REM-Sleep
Timeframe: Baseline Night, Experimental Night 1, Experimental Night 2, Experimental Night 3
Change in Arousal Index
Timeframe: Baseline Night, Experimental Night 1, Experimental Night 2, Experimental Night 3
Maximum Plasma Concentration (Cmax) of Dexmedetomidine
Timeframe: Up to 24 hours post-dose on Experimental Night 1, Experimental Night 2, and Experimental Night 3
Time to Maximum Plasma Concentration (Tmax) of Dexmedetomidine
Timeframe: Up to 24 hours post-dose on Experimental Night 1, Experimental Night 2, and Experimental Night 3
Area Under the Plasma Concentration-Time Curve From Time 0 to Last Measurable Point (AUC0-t) of Dexmedetomidine
Timeframe: Up to 24 hours post-dose on Experimental Night 1, Experimental Night 2, and Experimental Night 3
Change in Plasma Noradrenaline Concentration
Timeframe: Up to 24 hours post-dose on Experimental Night 1, Experimental Night 2, and Experimental Night 3